- Home
- CMPX vs AIP Comparison
CMPX vs AIP Comparison
Compare CMPX & AIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPX
- AIP
- Stock Information
- Founded
- CMPX 2014
- AIP 2003
- Country
- CMPX United States
- AIP United States
- Employees
- CMPX N/A
- AIP N/A
- Industry
- CMPX Biotechnology: Pharmaceutical Preparations
- AIP Semiconductors
- Sector
- CMPX Health Care
- AIP Technology
- Exchange
- CMPX Nasdaq
- AIP Nasdaq
- Market Cap
- CMPX 229.5M
- AIP 244.1M
- IPO Year
- CMPX N/A
- AIP 2021
- Fundamental
- Price
- CMPX $1.75
- AIP $5.82
- Analyst Decision
- CMPX Strong Buy
- AIP Strong Buy
- Analyst Count
- CMPX 8
- AIP 4
- Target Price
- CMPX $13.38
- AIP $12.75
- AVG Volume (30 Days)
- CMPX 2.8M
- AIP 166.0K
- Earning Date
- CMPX 05-12-2025
- AIP 05-01-2025
- Dividend Yield
- CMPX N/A
- AIP N/A
- EPS Growth
- CMPX N/A
- AIP N/A
- EPS
- CMPX N/A
- AIP N/A
- Revenue
- CMPX $850,000.00
- AIP $57,724,000.00
- Revenue This Year
- CMPX $47.65
- AIP $19.68
- Revenue Next Year
- CMPX $2,767.57
- AIP $18.13
- P/E Ratio
- CMPX N/A
- AIP N/A
- Revenue Growth
- CMPX N/A
- AIP 7.56
- 52 Week Low
- CMPX $0.77
- AIP $5.46
- 52 Week High
- CMPX $4.08
- AIP $12.64
- Technical
- Relative Strength Index (RSI)
- CMPX 41.42
- AIP 33.34
- Support Level
- CMPX $1.60
- AIP $5.80
- Resistance Level
- CMPX $1.78
- AIP $6.26
- Average True Range (ATR)
- CMPX 0.27
- AIP 0.47
- MACD
- CMPX 0.03
- AIP 0.00
- Stochastic Oscillator
- CMPX 38.01
- AIP 19.83
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.
About AIP Arteris Inc.
Arteris Inc is a provider of semiconductor system IP, including interconnect and other intellectual property, (collectively, System IP) technology. Its IP technology manages the on-chip communications and IP block deployments in System-on-Chip (SoC) semiconductors and systems of chiplets. Its proprietary System IP solutions achieve this by connecting client IP blocks such as processors, memories, artificial intelligence/machine learning (AI/ML) accelerators, graphics subsystems, safety and security, and other input/output subsystems (I/Os) via multiple Network-on-Chips (NoCs). The company operates in Americas, Asia Pacific and Europe, Middle East, out of which it derives maximum profit from Asia Pacific.